25 XP   0   0   10

Applied Therapeutics Inc
Buy, Hold or Sell?

Let's analyse Applied Therapeutics Inc together

PenkeI guess you are interested in Applied Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Applied Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Applied Therapeutics Inc

I send you an email if I find something interesting about Applied Therapeutics Inc.

Quick analysis of Applied Therapeutics Inc (30 sec.)










What can you expect buying and holding a share of Applied Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
4.8%

What is your share worth?

Current worth
$-0.16
Expected worth in 1 year
$-0.36
How sure are you?
23.8%

+ What do you gain per year?

Total Gains per Share
$-0.20
Return On Investment
-2.9%

For what price can you sell your share?

Current Price per Share
$6.85
Expected price per share
$3.22 - $9.39
How sure are you?
50%

1. Valuation of Applied Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)

$6.85

Intrinsic Value Per Share

$-2.78 - $-3.04

Total Value Per Share

$-2.94 - $-3.20

2. Growth of Applied Therapeutics Inc (5 min.)




Is Applied Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$17.1m$20.3m-$29.5m-322.6%

How much money is Applied Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$29.7m-$20.5m-$9.2m-31.1%
Net Profit Margin1,390.2%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Applied Therapeutics Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#981 / 1031

Most Revenue
#422 / 1031

Most Profit
#826 / 1031

Most Efficient
#20 / 1031

What can you expect buying and holding a share of Applied Therapeutics Inc? (5 min.)

Welcome investor! Applied Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Applied Therapeutics Inc.

What can you expect buying and holding a share of Applied Therapeutics Inc?

First you should know what it really means to hold a share of Applied Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Applied Therapeutics Inc is $6.85. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Applied Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Applied Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.16. Based on the TTM, the Book Value Change Per Share is $-0.05 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.14 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Applied Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.36-5.2%-0.28-4.1%-0.23-3.4%-0.22-3.2%-0.21-3.1%
Usd Book Value Change Per Share-0.06-0.8%-0.05-0.7%-0.14-2.0%-0.02-0.2%-0.01-0.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.06-0.8%-0.05-0.7%-0.14-2.0%-0.02-0.2%-0.01-0.1%
Usd Price Per Share3.35-1.98-1.19-11.79-11.23-
Price to Earnings Ratio-2.35--1.79--1.34--15.98--15.22-
Price-to-Total Gains Ratio-58.13--156.32--9.41-15.66-15.66-
Price to Book Ratio-20.69--24.23-9.81-13.08-12.46-
Price-to-Total Gains Ratio-58.13--156.32--9.41-15.66-15.66-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share6.85
Number of shares145
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.05-0.02
Usd Total Gains Per Share-0.05-0.02
Gains per Quarter (145 shares)-7.26-2.25
Gains per Year (145 shares)-29.04-9.02
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-29-390-9-19
20-58-680-18-28
30-87-970-27-37
40-116-1260-36-46
50-145-1550-45-55
60-174-1840-54-64
70-203-2130-63-73
80-232-2420-72-82
90-261-2710-81-91
100-290-3000-90-100

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.021.00.00.0%0.021.00.00.0%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%4.016.00.020.0%5.016.00.023.8%5.016.00.023.8%
Dividend per Share0.00.04.00.0%1.00.011.08.3%1.00.019.05.0%1.00.020.04.8%1.00.020.04.8%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%4.016.00.020.0%5.016.00.023.8%5.016.00.023.8%

Fundamentals of Applied Therapeutics Inc

About Applied Therapeutics Inc

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. The company's lead product candidate is AT-007 (also called govorestat) that has completed phase 3 for the treatment of galactosemia in healthy volunteers and adults, in pediatric clinical study for the treatment of galactosemia in kids, for treating enzyme sorbitol dehydrogenase, and for the treatment of phosphomannomutase enzyme-CDG. It also develops AT-001 (also called caficrestat) that is in phase 3 clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. The company has exclusive license and supply agreement with Mercury Pharma Group Limited to commercialize drug products containing AT-007. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.

Fundamental data was last updated by Penke on 2024-03-20 10:00:08.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Applied Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Applied Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Applied Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 5,649.0% means that $56.49 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Applied Therapeutics Inc:

  • The MRQ is 5,649.0%. The company is making a huge profit. +2
  • The TTM is 1,390.2%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ5,649.0%TTM1,390.2%+4,258.9%
TTM1,390.2%YOY-+1,390.2%
TTM1,390.2%5Y278.0%+1,112.1%
5Y278.0%10Y264.8%+13.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5,649.0%-171.8%+5,820.8%
TTM1,390.2%-205.8%+1,596.0%
YOY--262.1%+262.1%
5Y278.0%-455.6%+733.6%
10Y264.8%-589.0%+853.8%
1.1.2. Return on Assets

Shows how efficient Applied Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Applied Therapeutics Inc to the Biotechnology industry mean.
  • -68.7% Return on Assets means that Applied Therapeutics Inc generated $-0.69 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Applied Therapeutics Inc:

  • The MRQ is -68.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -65.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-68.7%TTM-65.4%-3.3%
TTM-65.4%YOY-31.9%-33.5%
TTM-65.4%5Y-34.3%-31.1%
5Y-34.3%10Y-34.2%-0.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-68.7%-12.5%-56.2%
TTM-65.4%-12.2%-53.2%
YOY-31.9%-11.2%-20.7%
5Y-34.3%-13.4%-20.9%
10Y-34.2%-14.7%-19.5%
1.1.3. Return on Equity

Shows how efficient Applied Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Applied Therapeutics Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Applied Therapeutics Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Applied Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-131.6%+131.6%
TTM-5Y-42.1%+42.1%
5Y-42.1%10Y-42.1%+0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--15.8%+15.8%
TTM--15.7%+15.7%
YOY-131.6%-13.9%-117.7%
5Y-42.1%-18.3%-23.8%
10Y-42.1%-19.2%-22.9%

1.2. Operating Efficiency of Applied Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Applied Therapeutics Inc is operating .

  • Measures how much profit Applied Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Applied Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of 606.6% means the company generated $6.07  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Applied Therapeutics Inc:

  • The MRQ is 606.6%. The company is operating very efficient. +2
  • The TTM is 126.2%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ606.6%TTM126.2%+480.4%
TTM126.2%YOY-+126.2%
TTM126.2%5Y25.2%+100.9%
5Y25.2%10Y24.0%+1.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ606.6%-299.1%+905.7%
TTM126.2%-210.1%+336.3%
YOY--279.7%+279.7%
5Y25.2%-459.9%+485.1%
10Y24.0%-596.9%+620.9%
1.2.2. Operating Ratio

Measures how efficient Applied Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of -31.02 means that the operating costs are $-31.02 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Applied Therapeutics Inc:

  • The MRQ is -31.016.
  • The TTM is -7.247.
Trends
Current periodCompared to+/- 
MRQ-31.016TTM-7.247-23.770
TTM-7.247YOY--7.247
TTM-7.2475Y-1.449-5.797
5Y-1.44910Y-1.380-0.069
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-31.0162.861-33.877
TTM-7.2473.193-10.440
YOY-3.615-3.615
5Y-1.4495.560-7.009
10Y-1.3807.396-8.776

1.3. Liquidity of Applied Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Applied Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.76 means the company has $0.76 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Applied Therapeutics Inc:

  • The MRQ is 0.764. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.837. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.764TTM0.837-0.073
TTM0.837YOY1.664-0.828
TTM0.8375Y4.364-3.527
5Y4.36410Y4.374-0.010
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7643.986-3.222
TTM0.8374.440-3.603
YOY1.6645.552-3.888
5Y4.3646.158-1.794
10Y4.3746.492-2.118
1.3.2. Quick Ratio

Measures if Applied Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Applied Therapeutics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.70 means the company can pay off $0.70 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Applied Therapeutics Inc:

  • The MRQ is 0.705. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.711. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.705TTM0.711-0.006
TTM0.711YOY1.843-1.132
TTM0.7115Y5.411-4.700
5Y5.41110Y5.355+0.056
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7053.638-2.933
TTM0.7114.168-3.457
YOY1.8435.515-3.672
5Y5.4116.012-0.601
10Y5.3556.209-0.854

1.4. Solvency of Applied Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Applied Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Applied Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.31 means that Applied Therapeutics Inc assets are financed with 131.3% credit (debt) and the remaining percentage (100% - 131.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Applied Therapeutics Inc:

  • The MRQ is 1.313. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.198. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.313TTM1.198+0.115
TTM1.198YOY0.687+0.511
TTM1.1985Y0.616+0.582
5Y0.61610Y0.597+0.019
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3130.335+0.978
TTM1.1980.330+0.868
YOY0.6870.267+0.420
5Y0.6160.367+0.249
10Y0.5970.378+0.219
1.4.2. Debt to Equity Ratio

Measures if Applied Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Applied Therapeutics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Applied Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY3.978-3.978
TTM-5Y0.933-0.933
5Y0.93310Y0.902+0.031
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.376-0.376
TTM-0.398-0.398
YOY3.9780.334+3.644
5Y0.9330.429+0.504
10Y0.9020.476+0.426

2. Market Valuation of Applied Therapeutics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Applied Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Applied Therapeutics Inc to the Biotechnology industry mean.
  • A PE ratio of -2.35 means the investor is paying $-2.35 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Applied Therapeutics Inc:

  • The EOD is -4.813. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.354. Based on the earnings, the company is expensive. -2
  • The TTM is -1.793. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.813MRQ-2.354-2.459
MRQ-2.354TTM-1.793-0.560
TTM-1.793YOY-1.339-0.454
TTM-1.7935Y-15.979+14.186
5Y-15.97910Y-15.218-0.761
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.813-2.643-2.170
MRQ-2.354-2.418+0.064
TTM-1.793-2.742+0.949
YOY-1.339-4.123+2.784
5Y-15.979-6.257-9.722
10Y-15.218-6.478-8.740
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Applied Therapeutics Inc:

  • The EOD is -10.663. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.215. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.705. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.663MRQ-5.215-5.448
MRQ-5.215TTM-3.705-1.509
TTM-3.705YOY-1.547-2.159
TTM-3.7055Y-18.952+15.247
5Y-18.95210Y-18.050-0.902
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-10.663-3.244-7.419
MRQ-5.215-2.939-2.276
TTM-3.705-3.478-0.227
YOY-1.547-5.592+4.045
5Y-18.952-8.473-10.479
10Y-18.050-8.881-9.169
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Applied Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -20.69 means the investor is paying $-20.69 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Applied Therapeutics Inc:

  • The EOD is -42.303. Based on the equity, the company is expensive. -2
  • The MRQ is -20.688. Based on the equity, the company is expensive. -2
  • The TTM is -24.231. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-42.303MRQ-20.688-21.615
MRQ-20.688TTM-24.231+3.543
TTM-24.231YOY9.814-34.045
TTM-24.2315Y13.084-37.314
5Y13.08410Y12.461+0.623
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-42.3032.124-44.427
MRQ-20.6882.041-22.729
TTM-24.2312.118-26.349
YOY9.8142.915+6.899
5Y13.0843.682+9.402
10Y12.4614.114+8.347
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Applied Therapeutics Inc.

3.1. Institutions holding Applied Therapeutics Inc

Institutions are holding 69.558% of the shares of Applied Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Franklin Resources Inc9.08710.0117017912-929100-11.6912
2023-09-30VR Adviser, LLC7.32631.4831565803400
2023-12-31Knoll Capital Management LP7.088915.187454746873125996.0557
2023-09-30Alyeska Investment Group, L.P.5.46510.07144220660-210746-4.7557
2023-09-30FMR Inc3.41780.0006263953600
2023-09-30Simplify Asset Management Inc.3.13030.68822417505348841.4641
2023-12-31HHG PLC2.78190.0043214846321484630
2023-09-30Parkman Healthcare Partners LLC2.2660.7984175000017500000
2023-12-31AIGH Capital Management, LLC2.14822.19871659039865689109.1182
2023-09-30Vanguard Group Inc1.84990.0001142865443165243.295
2023-12-31Opaleye Management Inc1.41460.9732109250019950022.3404
2023-12-31Rock Springs Capital Management LP1.15910.07388951958638610.6806
2023-12-31Renaissance Technologies Corp0.84560.003465308723760957.1893
2023-12-31BlackRock Inc0.68350.000152788614389337.4728
2023-12-31Longwood Capital Partners LLC0.67990.99025251005251000
2023-09-30Point72 Asset Management, L.P.0.6150.003547492900
2023-12-31Soleus Capital Management, L.P.0.59670.1713460793-731833-61.3632
2023-09-30Schonfeld Strategic Advisors LLC0.59230.00894574004574000
2023-09-30Geode Capital Management, LLC0.57420.000144347229670.6735
2023-12-31Worth Venture Partners, LLC0.53470.7477412981219008112.9064
Total 52.257123.415440357833+5543471+13.7%

3.2. Funds holding Applied Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-01-31Franklin Biotechnology Discv A(acc)USD10.02641.41769033878-818200-8.3048
2024-02-29Simplify Propel Opportunities ETF3.12717.195228175052000007.6409
2024-02-29Vanguard Total Stock Mkt Idx Inv2.31230.0012083448-313041-13.0625
2024-02-29Xtrackers S&P 500 Swap ETF 1C2.19910.1559198144119814410
2024-01-31Franklin Biotechnology Discovery A2.08240.6551876254-347200-15.6153
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.90960.00578195429423112.9918
2023-12-31HBM Healthcare Investments AG Ord0.3570.05432163400
2024-01-31Fidelity Extended Market Index0.34190.002730802400
2023-12-31Bridgeway Ultra-Small Company Market0.20530.33351850005000037.037
2023-09-30BlackRock Extended Mkt Composite0.16690.002715042000
2023-12-31BlackRock Extended Equity Market K0.14810.003213342119281.4662
2023-12-31Pleiades Small Cap Equity A0.11020.0379932600
2024-02-29EAM Ultra Micro Cap0.10310.780192872928720
2024-01-31Fidelity Total Market Index0.10260.00039246400
2024-01-31Fidelity Series Total Market Index0.08540.00047694400
2024-02-29iShares Micro-Cap ETF0.08270.05827452000
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.06530.000558824-477636-89.0348
2024-01-31Fidelity Nasdaq Composite Index0.06030.00125433700
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.05620.00275064700
2023-12-31Northern Trust Extended Eq Market Idx0.05560.002950077999824.9457
Total 22.597420.709820360578+474393+2.3%

3.3. Insider Transactions

Insiders are holding 7.106% of the shares of Applied Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-14Leslie D FuntleyderSELL287275.39
2024-03-14Riccardo PerfettiSELL1108045.39
2024-03-14Shoshana ShendelmanSELL3185735.39
2023-12-01Stacy J KanterBUY300002.18
2023-11-30Riccardo PerfettiSELL15831.97
2023-11-30Shoshana ShendelmanSELL39681.97
2023-11-02Real Estate Equitie AlexandriaSELL1038082.32
2023-10-31Real Estate Equitie AlexandriaSELL1550002.41
2023-09-27Riccardo PerfettiSELL109322.7
2023-09-27Shoshana ShendelmanSELL1156322.7

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Applied Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.058-0.050-13%-0.138+140%-0.016-73%-0.008-87%
Book Value Per Share---0.162-0.086-47%0.192-184%0.467-135%0.451-136%
Current Ratio--0.7640.837-9%1.664-54%4.364-82%4.374-83%
Debt To Asset Ratio--1.3131.198+10%0.687+91%0.616+113%0.597+120%
Debt To Equity Ratio----0%3.978-100%0.933-100%0.902-100%
Dividend Per Share----0%0.000-100%0.000-100%0.000-100%
Eps---0.356-0.283-21%-0.231-35%-0.218-39%-0.211-41%
Free Cash Flow Per Share---0.161-0.130-19%-0.184+15%-0.1600%-0.155-4%
Free Cash Flow To Equity Per Share--0.1170.046+157%-0.119+201%0.015+699%0.021+464%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---3.038--------
Intrinsic Value_10Y_min---2.778--------
Intrinsic Value_1Y_max---0.648--------
Intrinsic Value_1Y_min---0.637--------
Intrinsic Value_3Y_max---1.685--------
Intrinsic Value_3Y_min---1.614--------
Intrinsic Value_5Y_max---2.407--------
Intrinsic Value_5Y_min---2.256--------
Market Cap725325950.000+51%354721450.000209947449.250+69%125687869.000+182%1248852455.400-72%1189383290.857-70%
Net Profit Margin--56.49013.902+306%-+100%2.780+1932%2.648+2033%
Operating Margin--6.0661.262+381%-+100%0.252+2304%0.240+2424%
Operating Ratio---31.016-7.247-77%--100%-1.449-95%-1.380-96%
Pb Ratio-42.303-104%-20.688-24.231+17%9.814-311%13.084-258%12.461-266%
Pe Ratio-4.813-104%-2.354-1.793-24%-1.339-43%-15.979+579%-15.218+547%
Price Per Share6.850+51%3.3501.983+69%1.187+182%11.794-72%11.233-70%
Price To Free Cash Flow Ratio-10.663-104%-5.215-3.705-29%-1.547-70%-18.952+263%-18.050+246%
Price To Total Gains Ratio-118.867-104%-58.132-156.324+169%-9.407-84%15.658-471%15.658-471%
Quick Ratio--0.7050.711-1%1.843-62%5.411-87%5.355-87%
Return On Assets---0.687-0.654-5%-0.319-54%-0.343-50%-0.342-50%
Return On Equity----0%-1.3160%-0.4210%-0.4210%
Total Gains Per Share---0.058-0.050-13%-0.138+139%-0.016-73%-0.008-87%
Usd Book Value---17146000.000-9149000.000-47%20365250.000-184%49405900.000-135%47806476.190-136%
Usd Book Value Change Per Share---0.058-0.050-13%-0.138+140%-0.016-73%-0.008-87%
Usd Book Value Per Share---0.162-0.086-47%0.192-184%0.467-135%0.451-136%
Usd Dividend Per Share----0%0.000-100%0.000-100%0.000-100%
Usd Eps---0.356-0.283-21%-0.231-35%-0.218-39%-0.211-41%
Usd Free Cash Flow---17005000.000-13793250.000-19%-19523250.000+15%-16925500.0000%-16399000.000-4%
Usd Free Cash Flow Per Share---0.161-0.130-19%-0.184+15%-0.1600%-0.155-4%
Usd Free Cash Flow To Equity Per Share--0.1170.046+157%-0.119+201%0.015+699%0.021+464%
Usd Market Cap725325950.000+51%354721450.000209947449.250+69%125687869.000+182%1248852455.400-72%1189383290.857-70%
Usd Price Per Share6.850+51%3.3501.983+69%1.187+182%11.794-72%11.233-70%
Usd Profit---37679000.000-29760500.000-21%-20505750.000-46%-22306150.000-41%-21563904.762-43%
Usd Revenue---667000.0002498250.000-127%--100%499650.000-233%475857.143-240%
Usd Total Gains Per Share---0.058-0.050-13%-0.138+139%-0.016-73%-0.008-87%
 EOD+6 -2MRQTTM+11 -20YOY+19 -155Y+8 -2610Y+8 -26

4.2. Fundamental Score

Let's check the fundamental score of Applied Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.813
Price to Book Ratio (EOD)Between0-1-42.303
Net Profit Margin (MRQ)Greater than056.490
Operating Margin (MRQ)Greater than06.066
Quick Ratio (MRQ)Greater than10.705
Current Ratio (MRQ)Greater than10.764
Debt to Asset Ratio (MRQ)Less than11.313
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.687
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Applied Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.735
Ma 20Greater thanMa 506.527
Ma 50Greater thanMa 1004.782
Ma 100Greater thanMa 2003.668
OpenGreater thanClose6.700
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets54,833
Total Liabilities71,979
Total Stockholder Equity-17,146
 As reported
Total Liabilities 71,979
Total Stockholder Equity+ -17,146
Total Assets = 54,833

Assets

Total Assets54,833
Total Current Assets54,386
Long-term Assets447
Total Current Assets
Cash And Cash Equivalents 49,898
Net Receivables 285
Inventory 3,283
Other Current Assets 920
Total Current Assets  (as reported)54,386
Total Current Assets  (calculated)54,386
+/-0
Long-term Assets
Property Plant Equipment 447
Long-term Assets  (as reported)447
Long-term Assets  (calculated)447
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities71,182
Long-term Liabilities797
Total Stockholder Equity-17,146
Total Current Liabilities
Short-term Debt 739
Short Long Term Debt 310
Accounts payable 1,742
Other Current Liabilities 68,034
Total Current Liabilities  (as reported)71,182
Total Current Liabilities  (calculated)70,825
+/- 357
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt-272
Long-term Liabilities Other 759
Long-term Liabilities  (as reported)797
Long-term Liabilities  (calculated)487
+/- 310
Total Stockholder Equity
Common Stock8
Retained Earnings -468,586
Other Stockholders Equity 451,432
Total Stockholder Equity (as reported)-17,146
Total Stockholder Equity (calculated)-17,146
+/-0
Other
Capital Stock8
Cash and Short Term Investments 49,898
Common Stock Shares Outstanding 84,244
Current Deferred Revenue667
Liabilities and Stockholders Equity 54,833
Net Debt -49,121
Net Invested Capital -16,836
Net Working Capital -16,796
Property Plant and Equipment Gross 447
Short Long Term Debt Total 777



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
> Total Assets 
0
0
0
20,246
16,872
46,784
37,264
48,389
165,882
150,572
124,838
104,506
156,219
136,959
118,547
89,892
64,953
78,178
56,679
38,363
30,004
43,646
45,195
54,833
54,83345,19543,64630,00438,36356,67978,17864,95389,892118,547136,959156,219104,506124,838150,572165,88248,38937,26446,78416,87220,246000
   > Total Current Assets 
0
0
0
20,246
16,872
46,784
37,034
46,155
163,741
148,524
122,885
102,593
154,406
135,250
116,943
88,394
63,564
76,898
55,510
37,308
29,063
42,821
44,488
54,386
54,38644,48842,82129,06337,30855,51076,89863,56488,394116,943135,250154,406102,593122,885148,524163,74146,15537,03446,78416,87220,246000
       Cash And Cash Equivalents 
0
0
0
18,748
14,686
41,076
13,065
18,850
92,503
100,854
48,679
57,466
84,067
78,434
70,207
53,888
38,214
55,728
40,388
16,657
22,917
35,616
37,457
49,898
49,89837,45735,61622,91716,65740,38855,72838,21453,88870,20778,43484,06757,46648,679100,85492,50318,85013,06541,07614,68618,748000
       Short-term Investments 
0
0
0
0
0
0
19,889
20,004
61,806
37,644
67,826
39,363
63,992
47,182
38,595
26,935
17,437
11,994
6,990
13,923
0
0
0
0
000013,9236,99011,99417,43726,93538,59547,18263,99239,36367,82637,64461,80620,00419,889000000
       Net Receivables 
0
0
0
0
0
0
0
0
136
33
37
505
591
335
327
525
492
288
276
275
285
285
285
285
285285285285275276288492525327335591505373313600000000
       Other Current Assets 
0
0
0
1,498
2,186
5,708
525
91
131
440
522
280
213
500
473
471
7,421
8,888
8,132
1,131
6,146
536
1,792
920
9201,7925366,1461,1318,1328,8887,421471473500213280522440131915255,7082,1861,498000
   > Long-term Assets 
0
0
0
0
0
0
230
2,234
2,141
2,048
1,953
1,913
1,813
1,709
1,604
1,498
1,389
1,280
1,169
1,055
941
825
707
447
4477078259411,0551,1691,2801,3891,4981,6041,7091,8131,9131,9532,0482,1412,234230000000
       Property Plant Equipment 
0
0
0
0
0
0
0
2,035
2,141
2,048
1,953
1,913
1,813
1,709
1,604
1,498
1,389
1,280
1,169
1,055
941
825
707
447
4477078259411,0551,1691,2801,3891,4981,6041,7091,8131,9131,9532,0482,1412,0350000000
       Long Term Investments 
0
0
0
0
0
0
0
199
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000001990000000
       Other Assets 
0
0
0
0
0
0
230
199
199
199
199
1,913
201
201
200
200
199
199
199
0
0
197
0
0
00197001991991992002002012011,913199199199199230000000
> Total Liabilities 
0
0
0
4,428
44,789
6,780
6,517
15,782
10,054
20,368
21,898
22,567
20,998
24,519
31,846
27,353
22,990
52,370
47,050
34,302
34,076
47,980
56,239
71,979
71,97956,23947,98034,07634,30247,05052,37022,99027,35331,84624,51920,99822,56721,89820,36810,05415,7826,5176,78044,7894,428000
   > Total Current Liabilities 
0
0
0
4,428
6,328
6,780
6,517
14,099
8,466
18,876
20,502
21,235
19,774
23,405
30,843
26,462
22,217
51,715
46,514
33,424
33,251
47,188
55,504
71,182
71,18255,50447,18833,25133,42446,51451,71522,21726,46230,84323,40519,77421,23520,50218,8768,46614,0996,5176,7806,3284,428000
       Short-term Debt 
0
0
0
0
0
0
0
356
364
3,594
2,528
1,480
415
3,584
2,410
1,231
453
462
2,024
1,099
483
1,726
1,266
739
7391,2661,7264831,0992,0244624531,2312,4103,5844151,4802,5283,5943643560000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
3,222
2,148
1,074
0
3,158
1,974
789
0
2,487
1,554
622
0
1,240
775
310
3107751,24006221,5542,48707891,9743,15801,0742,1483,222000000000
       Accounts payable 
0
0
0
3,015
2,649
3,987
1,688
8,793
1,606
5,649
1,945
640
3,475
3,310
9,170
9,461
5,922
8,691
6,973
4,534
5,555
4,687
6,005
1,742
1,7426,0054,6875,5554,5346,9738,6915,9229,4619,1703,3103,4756401,9455,6491,6068,7931,6883,9872,6493,015000
       Other Current Liabilities 
0
0
0
1,413
3,679
2,793
4,829
264
447
783
770
553
522
576
657
987
15,842
42,562
37,517
27,791
27,213
26,453
37,167
68,034
68,03437,16726,45327,21327,79137,51742,56215,8429876575765225537707834472644,8292,7933,6791,413000
   > Long-term Liabilities 
0
0
0
0
38,461
38,461
0
1,683
1,588
1,492
1,396
1,332
1,224
1,114
1,003
891
773
655
536
878
825
792
735
797
7977357928258785366557738911,0031,1141,2241,3321,3961,4921,5881,683038,46138,4610000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
622
0
0
00622000000000000000000000
> Total Stockholder Equity
-3,961
0
0
15,818
-27,917
40,004
30,747
32,607
155,828
130,204
102,940
81,939
135,221
112,440
86,701
62,539
41,963
25,808
9,629
4,061
-4,072
-4,334
-11,044
-17,146
-17,146-11,044-4,334-4,0724,0619,62925,80841,96362,53986,701112,440135,22181,939102,940130,204155,82832,60730,74740,004-27,91715,81800-3,961
   Common Stock
0
0
0
0
0
1
1
1
2
2
2
2
3
3
3
3
3
5
5
5
5
6
7
8
876555533333222211100000
   Retained Earnings Total Equity00-388,537-358,96000000-239,156-210,738-184,910-160,73100000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
-46,784
11
-2
89
-29
-94
-112
-154
-185
-254
-107
-80
6
23
51
0
0
0
0
000051236-80-107-254-185-154-112-94-2989-211-46,78400000
   Capital Surplus 
0
0
0
0
2,070
78,427
79,872
99,378
234,876
0
0
242,780
320,282
323,360
326,108
0
0
0
0
0
354,883
384,197
0
0
00384,197354,88300000326,108323,360320,282242,78000234,87699,37879,87278,4272,0700000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 
0
0
0
37,075
-4,184
78,427
42,608
99,378
234,876
237,429
240,074
242,780
320,282
323,360
326,108
328,958
331,476
341,090
343,995
352,828
354,883
384,197
419,856
451,432
451,432419,856384,197354,883352,828343,995341,090331,476328,958326,108323,360320,282242,780240,074237,429234,87699,37842,60878,427-4,18437,075000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue9,993
Cost of Revenue-353
Gross Profit9,6409,640
 
Operating Income (+$)
Gross Profit9,640
Operating Expense-74,175
Operating Income-64,535-64,535
 
Operating Expense (+$)
Research Development53,905
Selling General Administrative20,623
Selling And Marketing Expenses-353
Operating Expense74,17574,175
 
Net Interest Income (+$)
Interest Income1,372
Interest Expense-0
Other Finance Cost-0
Net Interest Income1,372
 
Pretax Income (+$)
Operating Income-64,535
Net Interest Income1,372
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-119,763-9,307
EBIT - interestExpense = -64,535
-119,763
-119,763
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-64,535-119,763
Earnings Before Interest and Taxes (EBITDA)-64,182
 
After tax Income (+$)
Income Before Tax-119,763
Tax Provision-0
Net Income From Continuing Ops-119,763-119,763
Net Income-119,763
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses74,528
Total Other Income/Expenses Net-55,228-1,372
 

Technical Analysis of Applied Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Applied Therapeutics Inc. The general trend of Applied Therapeutics Inc is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Applied Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Applied Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 9.39.

The bearish price targets are: 5.36 > 4.42 > 3.22.

Tweet this
Applied Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Applied Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Applied Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Applied Therapeutics Inc. The current macd is 0.49983074.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Applied Therapeutics Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Applied Therapeutics Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Applied Therapeutics Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Applied Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartApplied Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Applied Therapeutics Inc. The current adx is 39.28.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Applied Therapeutics Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Applied Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Applied Therapeutics Inc. The current sar is 7.30105243.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Applied Therapeutics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Applied Therapeutics Inc. The current rsi is 62.74. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Applied Therapeutics Inc Daily Relative Strength Index (RSI) ChartApplied Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Applied Therapeutics Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Applied Therapeutics Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Applied Therapeutics Inc Daily Stochastic Oscillator ChartApplied Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Applied Therapeutics Inc. The current cci is 43.37.

Applied Therapeutics Inc Daily Commodity Channel Index (CCI) ChartApplied Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Applied Therapeutics Inc. The current cmo is 25.66.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Applied Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartApplied Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Applied Therapeutics Inc. The current willr is -26.60098522.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Applied Therapeutics Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Applied Therapeutics Inc Daily Williams %R ChartApplied Therapeutics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Applied Therapeutics Inc.

Applied Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Applied Therapeutics Inc. The current atr is 0.60639616.

Applied Therapeutics Inc Daily Average True Range (ATR) ChartApplied Therapeutics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Applied Therapeutics Inc. The current obv is 109,958,107.

Applied Therapeutics Inc Daily On-Balance Volume (OBV) ChartApplied Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Applied Therapeutics Inc. The current mfi is 60.12.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Applied Therapeutics Inc Daily Money Flow Index (MFI) ChartApplied Therapeutics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Applied Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-11-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-15MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-27MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-04BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Applied Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Applied Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.735
Ma 20Greater thanMa 506.527
Ma 50Greater thanMa 1004.782
Ma 100Greater thanMa 2003.668
OpenGreater thanClose6.700
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Applied Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Applied Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Applied Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Applied Therapeutics Inc

I send you an email if I find something interesting about Applied Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Applied Therapeutics Inc.

Receive notifications about Applied Therapeutics Inc in your mailbox!